Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Finished

BFORE Breakthrough Brain Stimulation Device for Epilepsy

Coordinator
Precisis GmbH, Germany
Runs
1 March 2023 to 28 February 2025
Status
Finished
EU funding
€2.5m
Total cost
€3.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190133715

What the project is doing

In the project's own words, from its summary on CORDIS.

EASEE® stands for epicranial application of stimulation electrodes in epilepsy. It is the first minimally invasive device for focal cortical stimulation. Based on the Laplace electrode (central electrode surrounded by a ring electrode), EASEE® features 4 distinct electrodes replacing the outer ring, connected to 4 independent current sources to account for impedance and anatomical variances in the human skull. Still, the characteristic quadrupolar local electric field with high penetration depth is maintained.

The stimulation pattern is one of a kind. EASEE® is equipped for high frequency, DC-like, and low-frequency stimulation, depending on the condition to be treated. In epilepsy, intermittent high-frequency stimulation bursts throughout the day are combined with a 20min DC-like stimulation session. This first is meant to terminate upcoming seizures, the second to initiate neuromodulatory processes to down-regulate the overexcitability of the epileptic brain area.

Topics

Who is involved

OrganisationCityCountryRole
Precisis GmbHHeidelbergGermanyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI